Devin Wenig, Director at NASTECH PHARMACEUTICAL CO INC (NSTK), sold 1,000 shares at $13.01 ($13K) on 2007-02-01, disclosed to the SEC on 2007-02-02.
Scheduled sale ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 300 | $4K | 29.8% |
| 2 | $13.01 | 200 | $3K | 19.9% |
| 3 | $13.03 | 100 | $1K | 10.0% |
| 4 | $13.05 | 100 | $1K | 10.0% |
| 5 | $13.07 | 100 | $1K | 10.0% |
| 6 | $13.22 | 100 |
| $1K |
| 10.1% |
| 7 | $13.38 | 100 | $1K | 10.2% |
| Total | $13.08 avg | 1,000 | $13K | 100% |
| Filing → |
| EBAY | SELL | 2019-07-03 | $398K | — | Filing → |
| EBAY | SELL | 2018-02-08 | $11.5M | — | Filing → |
| EBAY | SELL | 2013-10-31 | $2.4M | — | Filing → |